Founded in 1958, Jiangsu Lianshui Pharmaceutical Co., Ltd. is a modern pharmaceutical researching, trading and manufacturing enterprise, with 103mu of lands, 1,000 employees (300 of them are technicians), CNY 150 million of assets, CNY 200 million of sales incomes and CNY 20 million of annual tax and interest. At present, we mainly produce 4 types and over 100 kinds of products, including Injection, Tablets, capsule and granules; with outstanding performance, our products enjoy excellent reputation among clinic doctors and patents. Especially, our “Levofloxacin Lactate injection”, “Dextromethorphan hydrobromide injection”, “Lomefloxacin Hydrochloride injection” and “Itopride Hydrochloride”were approved as “hi-tech product” of Jiangsu province.
Quality is the lifeline of Lianshui. Through establishing GMP approved quality standards for capsules, we are working hard to offer you reliable drugs. Moreover, our injection and solid preparation plants also got the GMP certificates. There are 12 automatic production lines of injections now, we annually produce 1.2 billion pieces of injections; we now are a leading injection manufacturer in China, our injection products are well sold in China too. We invest CNY 10 million in our high standard quality inspection centre and zooscopy institutes in 2008. During the period of “Eleventh-five-year-program” of China, we will cost CNY 150 million and buy 70mu of lands to build our new pharmaceutical projects such as cerebrovascular & cardiovascular drug, antineoplastic medicine and so on; at the same time, we also will build other related facilities, we aim to be a large-scale modern pharmaceutical group.
Our development is based on technical innovations. We establish close cooperation relationships with dozens of universities and institutes in China, and we exchange our information and technologies frequently. There are 15 new products are under production now, and we are working hard on the R&D of 20 new medicines, 8 of them the latest drugs in China. Cooperating with Mr. Zhang Rongjiu (famous pharmaceutical expert, professor of China Pharmaceutical University and teach of doctoral student), we spent 3 years and successfully developed abidor granules, which was approved as the “second grade new drug” of China and got production license. As a new kind of flu drug, abidor granules are suitable for A/B influenza virus. Researched by Russian scientists and authenticated by Military Medical Science Academy of the PLA, this drug can kill HPAIV, SARS virus and hepatitis B virus, etc.
Our strategy is to get further development with the helps of talents. We want to be a learning enterprise, and offer all kinds of trainings to our staffs. Through executing goal responsibility management system in our company, we aim to encourage the team spirit and working passions of every staff by fair, just and challenging policies.
Our company has won various honors, such as " Trust company of China", "Provincial Civilized Enterprise", " Provincial High & New Technological Enterprise", "Provincial Excellent Enterprise for good measurement", "Provincial Advanced Collective in Environmental Protection", "Municipal First-Grade Enterprise in Innovation of Management", "Municipal Optimum Credit Enterprise", etc.
Upholding such tenet of " Dedicating ourselves into pharmaceutical fields, caring about human's health" and business idea of “human-orient, seeking for outstanding”, keeping the paces with time and daring to make innovation, we are striving to make a new plan for our business and trying our best to be a leading drug manufacturing enterprise in China.
